Tablets Based on Compressed Zein Microspheres for Sustained Oral Administration: Design,Pharmacokinetics,and Clinical Study

Abstract

In our previous study, we reported a novel tablet based on compressed zein microspheres as a universal drug delivery system using the hydrophobic protein zein, which shows zero-order release in the presence of pepsin. However, this formulation had difficulty with disintegration under physiological conditions within 48 h, and thus could not be used directly for oral administration. In the present study, a formulation of ivermectin (IVM) tablets based on compressed zein microspheres was improved as a new dosage form. The plasma disposition pharmacokinetics of IVM tablets based on compressed zein microspheres after oral administration was studied over a 7-day period with six dogs (Canis familiaris), using a commercial IVM tablet (5 mg/piece, Yilijia^® ) as a control. Clinical efficacy was tested using 270 dogs presented as veterinary patients for the treatment of demodicidosis. A formulation with disintegration time within 15 min could be obtained. The acquired C_max, T_max, and AUC were 9.89 ± 0.34 ng/mL, 11.33 ± 2.63 h, and 883.87 ng h/mL for IVM tablets based on compressed zein microspheres and 9.64 ± 1.05 ng/mL, 7.26 ± 2.09 h, and 666.30 ng h/mL for Yilijia^®, respectively. The bioavailability of the tablets based on compressed zein microspheres was 132.65% that of Yilijia^®. Efficacy for the dogs in all the IVM tablets based on compressed zein microspheres-treated groups reached 100% at 7, 14, and 21 days post administration.

Keywords

ivermectin zein tablets based on compressed zein microspheres pharmacokinetics oral administration.

Get full access to this article

View all access options for this article.

References

Shukla, R. and Cheryan, M. Zein: The Industrial Protein from Corn, Ind. Crops Prod., 2001: 14: 171-192.

Bernstein, H. , Morrel, E. , Mathlowitz , E. , Schwaller, K. and Thomas, R. Protein Microspheres and Methods of Using Them. US Patent No. 5679377; 1997.

Liu, L.S. , Kende, M. , Ruthel , G. , Fishman, M.L. and Hicks, K.B. Pectin/Zein Beads for Potential Colon-Specific Drug Delivery: Synthesis and In Vitro Evaluation , Drug Deliv. , 2006: 13: 417-423.

Liu, X.M. , Sun, Q.S. , Wang, H.J. , Zhang, L. and Wang, J.Y. Microspheres of Corn Protein, Zein, for an Ivermectin Drug Delivery System, Biomater., 2005: 26: 109-115.

Lifschitz, A. , Virkel, G. , Sallovitz , J. et al. Comparative Distribution of Ivermectin and Doramectin to Parasite Location Tissues in Cattle, Vet. Parasitol., 2000: 87: 327-338.

Lo, P.K. , Fink, D.W. , Williams, J.B. and Blodinger , J. Pharmacokinetic Studies of Ivermectin: Effects of Formulation, Vet. Res. Commun. , 1985: 9: 251-268.

Lifschitz, A. , Virkel, G. , Pis , A. et al. Ivermectin Disposition Kinetics after Subcutaneous and Intramuscular Administration of an Oil-based Formulation to Cattle, Vet. Parasitol., 1999: 86: 203-215.

Scott, E.W. , Kinabo, L.D. and McKellar, Q.A. Pharmacokinetics of Ivermectin after Oral or Percutaneous Administration to Adult Milking Goats, J. Vet. Pharmacol. Ther., 1990: 13: 432-435.

Laffont, C.M. , Alvinerie, M. , Bousquet-Mélou , A. and Toutain, P.L. Licking Behaviour and Environmental Contamination Arising from Pour-on Ivermectin for Cattle , Int. J. Parasitol., 2001: 31: 1687-1692.

10.

Lespine, A. , Sutra, J.F. , Dupuy, J. and Alvinerie, M. Eprinomectinin in Goat: Assessment of Subcutaneous Administration, Parasitol. Res., 2003: 89: 120-122.

11.

Gokbulut, C. , Karademir, U. , Boyacioglu, M. and McKellar, Q.A. Comparative Plasma Dispositions of Ivermectin and Doramectin Following Subcutaneous and Oral Administration in Dogs, Vet. Parasitol., 2006: 135: 347-354.

12.

Mueller, R.S. Treatment Protocols for Demodicosis: An Evidence-based Review, Vet. Dermatol., 2004: 15: 75-89.

13.

Wang, H.J. , Lin, Z.X. , Liu, X.M. , Sheng, S.Y. and Wang, J.Y. Heparin-loaded Zein Microsphere Film and Hemocompatibility, J. Control. Release, 2005: 105: 120-131.

14.

Kurita, T. , Miyagishima, A. , Nozawa, Y. , Sadzuka, Y. and Sonobe, T. A Dosage Design of Mitomycin C Tablets Containing Finely Powdered Green Tea , Int. J. Pharm., 2004: 275: 279-283.

15.

Ristic, Z. , Medleau, L. , Paradis, M. and White-Weithers, N.E. Ivermectin for Treatment of Generalized Demodicosis in Dogs, J. Am. Vet. Med. Assoc., 1995: 207: 1308-1310.

16.

Cerkvenik, V. , Grabnar, I. , Skubic , V. et al. Ivermectin Pharmacokinetics in Lactating Sheep, Vet. Parasitol., 2002: 104: 175-185.

17.

Gayrard, V. , Alvinerie, M. and Toutain, P.L. Comparison of Pharmacokinetic Profiles of Doramectin and Ivermectin Pour-on Formulations in Cattle, Vet. Parasitol., 1999: 81: 47-55.

18.

Gokbulut, C. , Karademir, U. and Boyacioglu, M. Comparison of Plasma Pharmacokinetic Profile of Ivermectin Following Administration of Subcutaneous Injection (Baymec (R)) and Oral Tablet (Efektin (R)) in Goats , J. Vet. Pharmacol. Ther., 2007: 30: 489-491.

19.

Simovic, S. , Hui, H. , Song , Y. , Davey, A.K. , Rades, T. and Prestidge, C.A. An Oral Delivery System for Indomethicin Engineered from Cationic Lipid Emulsions and Silica Nanoparticles, J. Control. Release, 2010: in press.

20.

Karakurum, M.C. , Ural, K. , Cingi , C.C. , Guzel, M. , Haydardedeoglu , A.E. and Borku, M.K. Evaluation of Ivermectin Tablets in the Treatment of Generalized Canine Demodicosis , Rev. Med. Vet., 2007: 158: 380-383.

21.

Dourmishev, A. , Serafimova, D. and Dourmishev, L. Efficacy and Tolerance of Oral Ivermectin in Scabies, J. Eur. Acad. Dermatol. Venereol., 1998: 11: 247-251.

22.

Dunyo, S.K. , Nkrumah, F.K. and Simonsen, P.E. Single-dose Treatment of Wuchereria Bancrofti Infections with Ivermectin and Albendazole Alone or in Combination: Evaluation of the Potential for Control at 12 Months After Treatment, Trans. R. Soc. Trop. Med. Hyg., 2000: 94: 437-443.